COLCIDOSE Trademark

Trademark Overview

On Tuesday, June 23, 2015, a trademark application was filed for COLCIDOSE with the United States Patent and Trademark Office. The USPTO has given the COLCIDOSE trademark a serial number of 86672106. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Tuesday, May 30, 2023. This trademark is owned by Gensco Laboratories, LLC. The COLCIDOSE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention of gout; Pharmaceutical preparations for the treatment of gout
colcidose

General Information

Serial Number86672106
Word MarkCOLCIDOSE
Filing DateTuesday, June 23, 2015
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateTuesday, May 30, 2023
Registration Number5087609
Registration DateTuesday, November 22, 2016
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 29, 2015

Trademark Statements

Goods and ServicesPharmaceutical preparations for the prevention of gout; Pharmaceutical preparations for the treatment of gout

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, June 30, 2015
Primary Code005
First Use Anywhere DateThursday, January 1, 2015
First Use In Commerce DateThursday, January 1, 2015

Trademark Owner History

Party NameGensco Laboratories, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressDoral, FL 33122
Party NameGensco Laboratories, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressDoral, FL 33122
Party NameGensco Laboratories, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressDoral, FL 33122

Trademark Events

Event DateEvent Description
Tuesday, May 30, 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Tuesday, May 30, 2023REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, May 30, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, November 18, 2022TEAS SECTION 8 & 15 RECEIVED
Monday, November 22, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, November 22, 2016REGISTERED-PRINCIPAL REGISTER
Tuesday, October 18, 2016NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, October 17, 2016ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Saturday, October 15, 2016STATEMENT OF USE PROCESSING COMPLETE
Thursday, October 13, 2016USE AMENDMENT FILED
Thursday, October 13, 2016TEAS STATEMENT OF USE RECEIVED
Wednesday, July 20, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 19, 2016SOU EXTENSION 1 GRANTED
Tuesday, May 24, 2016SOU EXTENSION 1 FILED
Saturday, June 25, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, May 24, 2016TEAS EXTENSION RECEIVED
Tuesday, November 24, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 29, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 29, 2015PUBLISHED FOR OPPOSITION
Wednesday, September 9, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, August 26, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, August 24, 2015ASSIGNED TO LIE
Wednesday, August 5, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 5, 2015EXAMINER'S AMENDMENT ENTERED
Wednesday, August 5, 2015NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, August 5, 2015EXAMINERS AMENDMENT E-MAILED
Wednesday, August 5, 2015EXAMINERS AMENDMENT -WRITTEN
Wednesday, July 29, 2015ASSIGNED TO EXAMINER
Tuesday, June 30, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, June 26, 2015NEW APPLICATION ENTERED

Related Keywords

colcidose gout pharmaceutical preparations treatment prevention